Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy
- PMID: 23807220
- PMCID: PMC3702285
- DOI: 10.1038/cddis.2013.211
Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy
Abstract
In most clinical trials, human mesenchymal stem cells (hMSCs) are expanded in vitro before implantation. The genetic stability of human stem cells is critical for their clinical use. However, the relationship between stem-cell expansion and genetic stability is poorly understood. Here, we demonstrate that within the normal expansion period, hMSC cultures show a high percentage of aneuploid cells that progressively increases until senescence. Despite this accumulation, we show that in a heterogeneous culture the senescence-prone hMSC subpopulation has a lower proliferation potential and a higher incidence of aneuploidy than the non-senescent subpopulation. We further show that senescence is linked to a novel transcriptional signature that includes a set of genes implicated in ploidy control. Overexpression of the telomerase catalytic subunit (human telomerase reverse transcriptase, hTERT) inhibited senescence, markedly reducing the levels of aneuploidy and preventing the dysregulation of ploidy-controlling genes. hMSC-replicative senescence was accompanied by an increase in oxygen consumption rate (OCR) and oxidative stress, but in long-term cultures that overexpress hTERT, these parameters were maintained at basal levels, comparable to unmodified hMSCs at initial passages. We therefore propose that hTERT contributes to genetic stability through its classical telomere maintenance function and also by reducing the levels of oxidative stress, possibly, by controlling mitochondrial physiology. Finally, we propose that aneuploidy is a relevant factor in the induction of senescence and should be assessed in hMSCs before their clinical use.
Figures
Similar articles
-
Human mesenchymal stem cells with enhanced telomerase activity acquire resistance against oxidative stress-induced genomic damage.Cytotherapy. 2017 Jul;19(7):808-820. doi: 10.1016/j.jcyt.2017.03.078. Epub 2017 Apr 25. Cytotherapy. 2017. PMID: 28454681
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
-
Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells.J Cell Physiol. 2011 Nov;226(11):2908-15. doi: 10.1002/jcp.22637. J Cell Physiol. 2011. PMID: 21302288
-
Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer.J Cell Mol Med. 2008 Aug;12(4):1347-59. doi: 10.1111/j.1582-4934.2008.00299.x. Epub 2008 Mar 4. J Cell Mol Med. 2008. PMID: 18318690 Free PMC article.
-
Endothelial cell senescence.Handb Exp Pharmacol. 2006;(176 Pt 2):213-48. doi: 10.1007/3-540-36028-x_7. Handb Exp Pharmacol. 2006. PMID: 17001772 Review.
Cited by
-
Cellular microenvironment: a key for tuning mesenchymal stem cell senescence.Front Cell Dev Biol. 2023 Dec 4;11:1323678. doi: 10.3389/fcell.2023.1323678. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38111850 Free PMC article. Review.
-
Phenotyping senescent mesenchymal stromal cells using AI image translation.Curr Res Biotechnol. 2023;5:100120. doi: 10.1016/j.crbiot.2023.100120. Epub 2023 Feb 1. Curr Res Biotechnol. 2023. PMID: 38045568 Free PMC article.
-
Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling.Stem Cell Res Ther. 2023 Oct 26;14(1):305. doi: 10.1186/s13287-023-03533-y. Stem Cell Res Ther. 2023. PMID: 37880755 Free PMC article.
-
Potential and Limitations of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells in Musculoskeletal Disorders Treatment.Biomolecules. 2023 Sep 4;13(9):1342. doi: 10.3390/biom13091342. Biomolecules. 2023. PMID: 37759742 Free PMC article. Review.
-
Establishing an hTERT-driven immortalized umbilical cord-derived mesenchymal stem cell line and its therapeutic application in mice with liver failure.J Tissue Eng. 2023 Sep 19;14:20417314231200328. doi: 10.1177/20417314231200328. eCollection 2023 Jan-Dec. J Tissue Eng. 2023. PMID: 37736245 Free PMC article.
References
-
- Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383–396. - PubMed
-
- Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462–471. - PubMed
-
- Duggal S, Brinchmann JE. Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells. J Cell Physiol. 2011;226:2908–2915. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
